In the latest issue of Glaucoma Today, iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM features as the only therapy currently available that reestablishes the physiological drainage pathway through the supraciliary route.
In his “Miniject: Harnessing the Drainage Power of the Supraciliary Space” article, glaucoma specialist Professor Dr Antonio Fea describes the history of the supraciliary space, and then describes in depth the MINIject implant, its STAR® material, the surgical procedure and clinical data.
“In clinical studies, the Miniject has demonstrated consistent, powerful, and sustained efficacy as a standalone treatment of patients with mild to moderate glaucoma and a favorable short- and long-term safety profile.”, stated Prof. Fea in the article.
Fea, Antonio. “Miniject: Harnessing the Drainage Power of the Supraciliary Space”, Glaucoma Today, September / October 2021.